The present disclosure relates to T24 nucleic acid sequences, amino acid sequences, and antibodies. Methods for detecting and diagnosing Taenia solium infection in a subject using the T24 sequences and specific binding agents are also disclosed. The T24 sequences disclosed herein can be formulated into a pharmaceutical composition for administration to a subject. For example, the disclosed T24 polypeptides can also be administered to a subject to stimulate an immune response in the subject, thereby protecting the subject against T. solium infection.

 
Web www.patentalert.com

< siRNA targeting cAMP-specific phosphodiesterase 4D

> Immunomodulatory constructs and their uses

> In vitro method for the diagnosis of neurodegenerative diseases

~ 00527